Australian rates will be normalised after avoiding the recession, says Simon Warner, head of Macro Markets at AMP Capital, speaking to CNBC's Karen Tso.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.